Australia's most trusted
source of pharma news
Monday, 24 November 2025
Monday, 24 November 2025
Subscribe
Login
'Fiasco sale' damages deal-making
With the Treasurer handing a US pharma a 'get out of jail free' card, questions are being asked about how it will affect future pharma deals in Australia
AbbVie lifts lid on cancer burden
New report exposes urgent need to address the heavy toll inflicted on patients, families, communities and the economy
TODAY
Who'll nab 2025's last PBS listings?
December PBS listings will mark the final reimbursement wins for 2025 and a dozen drugs are jostling for success
TODAY
$275 blunder opens huge market
Who forgot to pay a tiny patent maintenance fee, paving the way for generics to enter the monster obesity market?
21 November
AI threat no one is talking about
Australian pharma coach is warning of a deeper disruption to the workplace than job losses if guardrails aren't put in place
21 November
Best in Aussie Med Affairs gonged
Two new awards were launched at the MAPA Excellence Awards this year, which recognised six outstanding medical affairs professionals
20 November
March PBAC Agenda drops early
When PBAC meets in March, 32 companies will be chasing the first recommendations for 2026. See who's on the list
20 November
Latest Jobs
Finance Business PartnerTechnical Service & Warehouse CoordinatorCompliance & Legal DirectorSenior Portfolio Director - Clinical Research, ChinaAssociate Business Development Director - Clinical Research, JapanCustomer Service RepresentativeSenior Payroll OfficerHead of Sales26 more...
Pharma in Focus Jobs
Sales & Customer Relations (14)
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Brisbane
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Belrose
- Customer Service Representative - St Leonards
- Customer Service Representative - Belrose
- Inside Sales - Sydney
- Customer Service Representative - Macquarie Park
- Key Account Manager - Sydney
Clinical & Medical, R&D (6)
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Clinical Affairs Lead - Sydney
- QC Microbiologist - Broadmeadows
Regulatory, Pharmacovigilance & QA (5)
- Regulatory Affairs Specialist - Sydney
- Senior Quality Assurance Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
- Quality assurance associate - Sydney
- Pharmacovigilance Associate - Sydney
Executive Roles (3)
- Compliance & Legal Director - Macquarie Park
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Other (12)
- Finance Business Partner - Surry Hills
- Technical Service & Warehouse Coordinator - Alexandria
- Senior Payroll Officer - Melbourne
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
- Senior Recruitment Consultant - Sydney
- Senior Recruitment Consultant - Sydney
- Warehouse Assistant - Macquarie Park
- People and Culture Manager - Kingsgrove
- Technical Service & Warehouse Coordinator - Alexandria
- Service Administrator - Belrose
First 'Trojan Horse' drug wins nod
First-in-class drug ticked by the Regulator unlocks a new way of treating blood cancers, killing diseased cells from the inside
TODAY
Three blockbusters-to-be hit TGA
Drugs with big sales predictions, including a mega-blockbuster, have landed on the ARTG in a busy week for approvals
TODAY Approvals Action
Pharma votes for Best Workplace
ICYMI: See which company has been ranked the best place to work by pharma professionals plus the other top stories this week
21 November Your Week in 5 Minutes
Boost for multi-cancer funding
Strong results of a combination treatment across a variety of cancers highlights the need for broad cancer listings on the PBS
21 November
Trial points to better treatment
Study reveals the potential for more precise imaging of kidney cancer cells, allowing doctors to make better treatment choices
21 November
Blooms sets blistering pace
Hits major milestone with the recycling of 20 million blister packs, keeping more than 30,000kg of aluminum and plastic out of landfill
20 November
Top drugs expanding their patch
At the first meeting for 2026, PBAC will consider 22 changes to listings, almost half to add new disease indications
20 November
Mega-drug clears hurdle for listing
With a PBAC recommendation already under its belt, the TGA approval for this next-gen treatment has cleared the way for listing
20 November
Which pharma hit AFR Fast 100?
This pharma found a niche of unmet need, and by filling it has been recognised as one of our fastest-growing companies
19 November
CSL joins US manufacturing rush
Aussie giant joins a long line of pharma companies expanding their US footprint in the wake of Donald Trump's tariff threats
19 November
Tough times? Not for all pharmas
Overall market cap for the industry is up but it hides a dramatic difference in the results of individual pharmas
19 November
J&J buys 'cancer revolution' asset
It's nowhere near the most expensive acquisition this year but this buyout could create the next generation of oral cancer treatments
19 November
Workforce crisis needs investment
New white paper launched by ARCS urges workforce system reform to keep Australia a top-tier clinical trials destination
19 November
Aussie Novo dodges major job cuts
Despite axing 9000 jobs, the impact locally has been limited although the exact number of Aussie jobs gone remains undisclosed
18 November